Connect with us

Published

on

The private equity firm at the centre of a string of bidding wars for British companies is leading the £1.7bn race to buy the owner of Argos’s store-card operations.

Sky News has learnt that KKR is the frontrunner to buy NewDay Group, which is owned by the buyout firms Cinven and CVC Capital Partners.

KKR is not in exclusive talks, and other parties – said to include Pimco, the asset management giant, KKR, and a Bain Capital-led consortium – remain in contention to acquire NewDay.

Some of the bidders, such as Pimco, have been interested in pursuing a deal to buy NewDay’s consumer loan book rather than the company as a whole; others including KKR are understood to be interested in acquiring the whole business, but potentially with its existing shareholders remaining invested for a period of time.

NewDay, which took ownership of Argos’s store card business last year in a £720m deal with J Sainsbury, the supermarket giant, has been exploring a sale or stock market listing for months.

Last November, Sky News reported that NewDay’s owners were lining up investment bankers at Barclays to advise on a process.

NewDay is one of Britain’s biggest privately held providers of consumer credit services, with about four million customers.

More from Money

Last year, it reported £213m of underlying pre-tax profit, with new customer acquisitions up 36%.

It also launched a technology and lending partnership with Lloyds Banking Group, and launched the pilot of a technology partnership with Debenhams Group in the final quarter of last year.

KKR has become engaged in bidding wars in recent months for Assura, the GP surgeries landlord, and testing equipment provider Spectris – both of which are listed on the London stock market.

NewDay, KKR and CVC declined to comment.

Continue Reading

Business

UK boosts pandemic readiness with new vaccine factory

Published

on

By

UK boosts pandemic readiness with new vaccine factory

A US vaccine firm has opened the first mRNA manufacturing plant in the UK, against a backdrop of increasing anti-jab rhetoric back home.

The new facility outside Oxford is part of a £1bn investment in the UK by Moderna, which specialises in mRNA.

The novel vaccine technology delivered some of the most effective and fastest-to-develop jabs during the COVID pandemic.

Several pharma companies, including Germany’s leading mRNA pioneer BioNTech, are now racing to develop new therapies.

Moderna says the plant will produce up to 100 million doses of its existing vaccine products each year. It has also been designed to scale-up production to 250 million doses a year in the event of a new disease outbreak.

“God-forbid, if there is another pandemic, we can switch the facility any day,” said Moderna CEO Stephane Bancel.

The UK investment deal was agreed by the previous government, but the plant’s opening is welcome relief for the current one.

In recent weeks, four major pharmaceutical companies have halted planned investments in the UK following disputes over drug pricing and profitability in the UK.

‘A great statement’

It also promises to restore domestic vaccine manufacturing capability in the UK, the lack of which was exposed when dangerous supply interruptions threatened the early COVID response.

“It’s a really fast way of getting new vaccines discovered,” said Lord Patrick Vallance, former chief scientist and now science minister.

“It’s also a great statement of confidence in the UK that [Moderna has] chosen to base themselves here.”

Health Secretary Wes Streeting attended the opening
Image:
Health Secretary Wes Streeting attended the opening

Moderna: UK ‘still believes’ in vaccines

The mRNA molecule is the same used by our cells to order the production of new proteins, and allows vaccines to be produced using just the genetic code of a virus or other biological target.

Moderna’s investment decision pre-dated Donald Trump’s return to the White House, but the Moderna CEO said its operation in the UK – a country that “still believes in vaccination” – may pay dividends if anti-vaccine rhetoric translates into a lack of demand for its products in the US.

“If there is less appetite by governments around the world, including in the US, to use vaccines, we might invest less in vaccines,” said Mr Bancel.

“We have to invest where there’s a demand for our products.”

Read more: All health claims made by Trump – and what experts say

Please use Chrome browser for a more accessible video player

Is US politics fuelling a deadly measles outbreak?

The UK presents other attractions for the company which has suffered substantial losses as demand for its COVID vaccine has fallen.

It’s betting that leading UK universities and a large patient population will make for successful clinical trials.

The company has ongoing NHS trials of new jabs against seasonal flu, a combination COVID and flu vaccine, cancer vaccines and mRNA therapies for two inherited childhood diseases.

Moderna says it is now the largest private commercial sponsor of clinical trials in the UK.

Continue Reading

Business

Man banned from every Boots store

Published

on

By

Man banned from every Boots store

A shoplifter has been jailed and banned from every Boots store after stealing £107,000 worth of goods from the high street chain.

Liam Hutchinson, 32, of no fixed address, was sentenced to a year in prison at Westminster Magistrates’ Court on Wednesday.

He was also issued with a criminal behaviour order, banning him from every Boots store in the UK for 10 years – and the London borough of Kensington and Chelsea for five years.

Metropolitan Police detectives trawled through hours of CCTV footage to find that Hutchinson had committed 99 shoplifting offences at Boots stores in the borough between May and August 2025.

Hutchinson stealing from shelves in Boots on CCTV. Pic: Met Police
Image:
Hutchinson stealing from shelves in Boots on CCTV. Pic: Met Police

Often stealing large quantities of razors and electrical items, his crimes cost the retailer £107,000 in revenue, Sergeant Jack Vine, of the Met’s volume crime team said.

“We recognised the impact Hutchinson’s actions were having on the retailer, and through working with staff, we built a strong case of evidence against him, which has been reflected in his sentencing,” he added.

“This result should act as a warning that this type of behaviour will not be tolerated, and that we will come down hard on those who show a complete disregard for the law, terrorise retail workers and cost businesses thousands of pounds.”

Liam Hutchinson being caught by officers in bodycam footage. Pic: Met Police
Image:
Liam Hutchinson being caught by officers in bodycam footage. Pic: Met Police

Read more from Sky News
Remains found in ‘no body’ case
Fire at airport causes delays
London mayor says Donald Trump is Islamophobic

Nicky Harrop, head of security, fraud, and contract management at Boots, said the company have been investing “significantly” in anti-theft measures to make sure stores “remain a safe and respectful environment” for customers and staff.

The Met says it is prioritising shoplifting, having solved 163% more cases in London compared to the same time last year.

It is also dedicating up to 80 additional officers across London’s West End, with 90 more in high-risk theft areas.

Continue Reading

Business

Sky News coverage to be featured on MSNBC as part of commercial agreement

Published

on

By

Sky News coverage to be featured on MSNBC as part of commercial agreement

Sky News has reached a multi-year deal with one of the most influential US news networks, which will see it pay for use of its cross-platform coverage. 

The channel’s live broadcasts, TV packages and online journalism are to be used by MSNBC as part of a commercial agreement, the details of which were not disclosed.

Money latest: Bank launches sub-4% mortgage in ‘turning point’ for borrowers

All Sky News’ British and foreign TV coverage is included in the agreement, which will begin on 1 October, further bringing the reporting to a US audience.

MSNBC will have no role in the commissioning of Sky coverage, and no MSNBC programming will be taken by Sky News, as part of the arrangement.

MSNBC is building up its operations ahead of its planned spin-off from NBC News and parent company Comcast.

The new, separated entity will be named Versant and be a public company with shares traded on a stock exchange.

More from Money

Comcast is also the parent company of Sky News. Sky’s relationship with its sister news organisation NBC will be unaffected by the deal.

More than 500 journalists work for Sky News from 11 bureaus, including Moscow, Beijing, Jerusalem, and Johannesburg.

MSNBC is a major cable news network, watched by an average of 1.2 million viewers a day, so far this year, with its average viewer watching for more than eight hours a week.

Its YouTube and TikTok channels have more than 6.2 billion views combined so far this year.

“In this moment of consequential and historic news events happening around the world that are rapidly reshaping our collective future, we are honoured to bring Sky News’ premium, on-the-ground reporting and roster of top journalists to the MSNBC community,” said MSNBC president Rebecca Kutler.

Continue Reading

Trending